The Medicines Company (NASDAQ:MDCO) reported first quarter earnings of 21 cents per share, including the impact of stock-based compensation expense. First quarter earnings, while well above the Zacks Consensus Estimate of 11 cents, declined 65% from the year-ago earnings.
Although first quarter 2012 revenues were higher, higher operating expenses led to the year-over-year decline in earnings. Revenues, up 12.9% at $126.6 million, were above the Zacks Consensus Estimate of $124 million.
The Quarter … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards